Tangshan Workers' Hospital
Welcome,         Profile    Billing    Logout  
 21 Trials 
35 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Liu, Jing
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting
4
8250
RoW
Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy
Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases
04/25
04/25
ECLIPSE, NCT05416840: Effects and Safety of Clonidine Patch on Young and Middle-aged Smokers With Mild Hypertension

Not yet recruiting
4
92
RoW
Clonidine controlled-release patch, Amlodipine
Jing Liu
Hypertension
11/26
12/26
NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）

Recruiting
3
1630
RoW
Alteplase, rt-PA, Tenecteplase, TNK-tPA
Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd
Acute Ischemic Stroke
11/23
03/24
BENCH, NCT04939142: A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Active, not recruiting
3
150
RoW
SVd (Selinexor+Bortezomib+dexamethasone), Vd (Bortezomib+dexamethasone)
Antengene Corporation
Relapsed or Refractory Multiple Myeloma
07/24
10/24
MATINEE, NCT04133909 / 2018-001540-56: Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

Jan 2024 - Dec 2024: Acceptance of regulatory submission in US (based on MATINEE trial) for COPD
Jan 2024 - Dec 2024: Acceptance of regulatory submission in EU (based on MATINEE trial) for COPD
Jan 2024 - Dec 2024: Data from MATINEE trial for COPD
Jan 2024 - Dec 2024: Acceptance of regulatory submission in China (based on MATINEE trial) for COPD
Hourglass Jul 2024 - Dec 2024 : Regulatory decision in Japan for COPD
Completed
3
806
Europe, Canada, US, RoW
Placebo, Mepolizumab
GlaxoSmithKline, PPD DEVELOPMENT, LP
Pulmonary Disease, Chronic Obstructive
08/24
08/24
NCT04578613: ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL

Recruiting
3
218
RoW
ICP-022, Chlorambucil, Rituximab
Beijing InnoCare Pharma Tech Co., Ltd.
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
12/24
06/25
NCT06532539: Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Recruiting
2
30
RoW
Paclitaxel and Cisplatin, TP, Cadonilimab, AK104, Radiotherapy
Shandong Cancer Hospital and Institute
Endometrial Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis
05/25
05/26
NCT04970121: Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy

Recruiting
2
100
RoW
Duloxetine, Chemotherapy containing taxanes
Yan Yang, MD, Ph.D
Chemotherapy-induced Peripheral Neuropathy, Pain, Solid Tumor
07/25
12/25
NCT06757504: Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD

Recruiting
2
150
RoW
TTYP01 Tablets (12mg or 18mg), Placebo (Simulant TTYP01 Tablets)
Shanghai Auzone Biological Technology Co., Ltd.
Autism Spectrum Disorder (ASD)
02/26
05/26
FUMANBA-1, NCT05066646: A Phase 1/2 Study of a Fully Human BCMA-targeting CAR (CT103A) in Patients With Relapsed/Refractory Multiple Myeloma

Recruiting
1/2
132
RoW
CT103A
Nanjing IASO Biotherapeutics Co.,Ltd
Multiple Myeloma
10/22
06/24
LUMMICAR STUDY 1, NCT03975907: Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma

Active, not recruiting
1/2
121
RoW
CAR-BCMA T Cells
CARsgen Therapeutics Co., Ltd., Beijing Chao Yang Hospital, The First Affiliated Hospital of Soochow University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Tianjin Medical University General Hospital, First Affiliated Hospital of Zhejiang University, Beijing Hospital, Shanghai Tongji Hospital, Tongji University School of Medicine, First Affiliated Hospital of Wenzhou Medical University, Xiangya Hospital of Central South University, Peking University People's Hospital, Qilu Hospital of Shandong University, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University
Multiple Myeloma
12/24
12/25
NCT04711980: Post-marketing Evaluation of Mudan Granule Intervention on Type 2 Diabetic Peripheral Neuropathy

Not yet recruiting
1
402
RoW
Mudan granule, Mudan particle, Placebo, Placebos
Fengmei Lian, Peking Union Medical College Hospital, Beijing Hospital, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Affiliated Hospital of Qingdao University, Chengdu University of Traditional Chinese Medicine, The Fourth People's Hospital of Chongqing, Zhengzhou Yihe Hospital Affiliated to Henan University, Zhu Xianyi Memorial Hospital of Tianjin Medical University, The Third Hospital of Xi'an, Huashan Hospital, Gansu Provincial People's Hospital, Shenzhen Hospital of Guangzhou University of Traditional Chinese Medicine, Affiliated Hospital of Changchun University of Chinese Medicine
Diabetic Peripheral Neuropathy Type 2
02/22
09/22
NCT05627063: A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors

Recruiting
1
169
US, RoW
ABSK121-NX
Abbisko Therapeutics Co, Ltd
Solid Tumor
03/25
06/25
CMCS, NCT04253054: Chinese Multi-provincial Cohort Study-Beijing Project

Enrolling by invitation
N/A
3000
RoW
Cardiovascular risk factors, Aging related health problems
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Cardiovascular Diseases, Cardiovascular Risk Factor, Aging Problems, Smell Disorder, Sleep
03/21
03/21
NCT04658992: The Registration on the Use of Feilike Heji in Minors

Recruiting
N/A
3000
RoW
China Academy of Chinese Medical Sciences
Bronchial Asthma
12/21
03/22
NCT04714918: Chinese CKD-MBD Prevalence Survey (CRISS-MBD)

Recruiting
N/A
10254
RoW
Limeng Chen
Chronic Kidney Diseases, Chronic Kidney Disease-Mineral and Bone Disorder
12/24
12/24
NCT06211166: Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction

Recruiting
N/A
300
RoW
Digital PCR, Quantitative PCR, MFC
Peking University People's Hospital
Acute Leukemia, MDS, MDS/MPN, CML
12/25
12/27
NCT05774288: Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders.

Recruiting
N/A
244
RoW
Cera™ patent foramen ovale occluders, Another patent foramen ovale occluders
Lifetech Scientific (Shenzhen) Co., Ltd.
Patent Foramen Ovale, Cryptogenic Stroke
04/25
06/29
NCT05423275: Light and Ion Maintenance In Treatment for Depression (LIMIT-D): Feasibility Study

Recruiting
N/A
100
Canada
Negative ion therapy, Light therapy
University of British Columbia, University of Toronto, Université de Montréal, Canadian Institutes of Health Research (CIHR), McMaster University, Ontario Brain Institute, Centre for Addiction and Mental Health
Major Depressive Disorder, Recurrent, in Remission
12/26
06/27
SMART, NCT05409898: Screening for Masked Hypertension With Smart Wearable Devices

Not yet recruiting
N/A
200
RoW
smart wearable device
Jing Liu, HUAWEI
Masked Hypertension
06/24
07/24
NCT05498974: China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

Recruiting
N/A
20000
RoW
Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center
Second Xiangya Hospital of Central South University
Type1diabetes, Diabetes
12/35
12/35
Li, Yongqiu
NCT05908695: An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease

Recruiting
4
1312
RoW
GV-971, Placebo
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Alzheimer's Disease
06/29
12/29
CRAD-001-03, NCT05295173: A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）

Completed
3
1412
RoW
Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA
Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital
Acute Ischemic Stroke
06/23
06/23
COAST, NCT03653156: China Cognition and Aging Study

Recruiting
N/A
100000
RoW
Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Hunan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, Wuhan University Zhongnan Hospital, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital
Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD), Normal Control, Non-Alzheimer Degenerative Dementia
01/38
01/38
CFAN, NCT03657732: The Chinese Familial Alzheimer's Network

Recruiting
N/A
40000
RoW
Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Henan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, Wuhan University Zhongnan Hospital, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital
Alzheimer Disease, Familial Alzheimer Disease (FAD)
01/38
01/38
Fang, Hui
RECAM, NCT04807348: Chiglitazar Added to Metformin for Type 2 Diabetes

Completed
3
533
RoW
Chiglitazar 32mg, Bilessglu, CS038, Chiglitazar 48mg, Placebo, Chiglitazar simulator, Metformin Hydrochloride, Glucophage
Chipscreen Biosciences, Ltd.
Type 2 Diabetes
02/23
02/23
NCT06738979: A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects

Not yet recruiting
3
408
RoW
TQF3510 (Semaglutide Injection), Wegovy®
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Obesity
07/26
08/26
NCT06606509: The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).

Not yet recruiting
N/A
1000
RoW
Continuous Glucose Monitoring System (GX-01S)
Nanjing First Hospital, Nanjing Medical University
Type1 Diabetes Mellitus
10/26
06/27
xu, xiang
NCT04991493: Effect of Tramadol on Postoperative Sore Throat After General Anesthesia

Recruiting
4
168
RoW
Tramadol hydrochloride, Tramadol, Normal Saline
Affiliated Cancer Hospital of Shantou University Medical College
Post-operative Sore Throat, Intubation Intratracheal, Thyroid Surgery
11/23
07/24
NCT06368622: Evolve China PMCF Study

Recruiting
N/A
500
RoW
Surpass Evolve Flow Diverter System
Stryker Neurovascular, Stryker (Beijing) Healthcare Products Co., Ltd
Intracranial Aneurysm
11/27
08/31
LIGHT-MCI, NCT05313529: Evaluating the Effects of Liraglutide, Empagliflozin and Linagliptin on Mild Cognitive Impairment Remission in Patients With Type 2 Diabetes: a Multi-center, Randomized, Parallel Controlled Clinical Trial With an Extension Phase

Recruiting
N/A
396
RoW
Liraglutide, metformin, Empagliflozin, Linagliptin
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing First Hospital, Nanjing Medical University, The Affiliated Jiangning Hospital of Nanjing Medical University, Wuxi People's Hospital, Changzhou No.2 People's Hospital
Type 2 Diabetes Mellitus, Mild Cognitive Impairment
12/26
12/27
Luo, Tao
NCT06399185: Effect of Dexmedetomidine and Esketamine on Catheter-related Bladder Discomfort

Recruiting
4
1740
RoW
Normal saline, Placebo, Dexmedetomidine, Esketamine, Combined dexmedetomidine-esketamine
Peking University First Hospital, Peking University Shenzhen Hospital
Urinary Catheter, Catheter-related Bladder Discomfort, Dexmedetomidine, Esketamine
04/27
05/27
NCT06256354: Effects of Intraoperative Targeted Temperature Management on Incidence of Postoperative Delirium and Long-term Survival

Recruiting
N/A
3992
RoW
Routine thermal management, Target temperature management
Peking University First Hospital, Peking University
Hypothermia, Delirium, Long-term Survivors, Cancer Surgery
02/29
01/30
NCT06482749: Repetitive Transcranial Magnetic Stimulation and Postoperative Neurocognitive Recovery

Not yet recruiting
N/A
568
RoW
Repetitive transcranial magnetic stimulation, Sham stimulation
Peking University First Hospital, Xijing Hospital, Air Force Medical University, Peking University Shenzhen Hospital
Older Patients, Cognitive Impairment, Repetitive Transcranial Magnetic Stimulation, Delayed Neurocognitive Recovery, Postoperative Neurocognitive Disorder
08/28
12/29
NCT06030804: Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery

Recruiting
N/A
4532
RoW
Dexmedetomidine, Dexmedetomidine hydrochloride, Placebo, Normal saline
Peking University First Hospital, Peking University
Elderly, Cancer Surgery, Dexmedetomidine, Long-Term Survivors
09/25
10/28

Download Options